to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
With a decade of experience in venture capital, Erik has been a catalyst for Cleantech in Silicon Valley and abroad. He leads MDV's Cleantech investment team and applies his expertise in areas of solar, biofuels, energy
storage, industrial biotech and clean coal. Prior to MDV Erik worked at Interval Research Corp., a technology incubator funded by Paul Allen, and at Los Alamos National Laboratory as a technical staff member. He also consulted to several
seed and early stage venture capital firms. While pursuing a PhD in engineering at Stanford, Erik led an interdisciplinary project between the electrical, mechanical, and civil engineering departments to develop a next-generation
monitoring system for critical facilities. He holds a U.S. patent from his research work. Erik serves on the advisory council of the Stanford Precourt Institute for Energy Efficiency, as well as on the advisory boards of the Stanford
Technology Ventures Program (STVP), Stanford's BASES, NVCA Cleantech Council, and Cleantech Venture Network. He is a winner of the 2006 World Technology Award for Finance, presented by the World Technology Network, in association with the
New York Stock Exchange (NYSE), Dow Chemical, Cisco, TIME magazine, Fortune magazine, Science magazine/AAAS, Red Herring, and CNN. Erik earned a bachelor's degree in engineering from Harvey Mudd College and both doctoral and master's
degrees from the Stanford University School of Engineering.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Dr. Larry Brilliant is the Executive Director of Google.org, where he leads major initiatives aimed at reducing global poverty, improving the health of the least advantaged in the world, and working to halt the effects
of the climate crisis. Larry is an M.D. and M.P.H., board-certified in preventive medicine and public health. He is a founder and director of The Seva Foundation, which works in dozens of countries around the world, primarily to eliminate
preventable and curable blindness. He serves as a member of the strategic advisory committee for Kleiner Perkins (KPCB) Venture Capital and also sits on the boards of The Skoll Foundation, Health Metrics Network, Omidyar Networks Humanity
United, and InSTEDD, an organization bringing technological tools to improve disaster response. In addition to his medical career, Larry co-founded The Well, a pioneering virtual community, with Stewart Brand in 1985. He also holds a
telecommunications technology patent and has served as CEO of two public companies and other venture-backed start-ups. The author of two books and dozens of articles on infectious diseases, blindness, and international health policy, Larry
has worked at every level of government. He was recently a "first responder" for CDC's smallpox bio-terrorism response effort, volunteered in Sri Lanka for tsunami relief, and established an interdisciplinary consultancy to prepare for
possible pandemic influenza. Larry lived in India working as a United Nations medical officer for more than a decade where he played a key role in the successful World Health Organization (WHO) smallpox eradication program and has recently
worked for the WHO polio eradication effort as well. He was Associate Professor of epidemiology, global health planning and economic development at the University of Michigan. Larry earned a Masters in Public Health in health planning and
economic development from the Univ
As the president of Yahoo! Inc., Susan L. Decker is a key participant in determining Yahoo!'s business strategy and vision. She is responsible for all of the global business operations of Yahoo!, including sales, product
marketing, and distribution across the three major customer groups of audience, advertisers, and publishers. Prior to that, from December 2006 - June 2007, she served as the head of one of Yahoo!'s two major business units, the Advertiser
and Publisher Group (APG). In that role, she was instrumental in developing the company's recent reorganization plan and strategy to transform how advertisers connect with their target customers online. Preceding her work with APG, Decker
was Executive Vice President and Chief Financial Officer for seven years, managing all aspects of the company's financial and administrative direction within key functional areas, including finance, facilities, investor relations (and
human resources and legal through December 2006). Decker served on the board of directors of Pixar Animation Studios from June 2004 to May 2006 until its sale to Disney, and currently serves on the board of directors for Berkshire
Hathaway, Intel Corporation, and Costco Wholesale. She holds a Bachelor of Science degree from Tufts University, with a double major in computer science and economics, and an MBA from Harvard Business School.
Dr. Diamandis is the Chairman and CEO of the X PRIZE Foundation, which awarded the $10,000,000 Ansari X PRIZE for private spaceflight. Diamandis is focused on building the X PRIZE Foundation into a world-class prize
institute. The X PRIZE is now developing X PRIZEs in Genomics, Automotive, Education, Medicine, Energy, and Social fields. He is also an international leader in the commercial space arena, having founded and run many of the sector's
leading entrepreneurial companies. Diamandis serves as the CEO of Zero Gravity Corporation, a commercial space company developing private, FAA-certified parabolic flights utilizing Boeing 727-200 aircraft. In addition, he is the chairman
and co-founder of the Rocket Racing League. Diamandis is a co-founder and director of Space Adventures, the company that brokered the launches of four private citizens to the International Space Station. In 1987, Diamandis co-founded the
International Space University (ISU), where he served as the University's first managing director. Today he is a trustee of the $30M ISU, based in Strasbourg, France. Prior to ISU, Diamandis was chairman of Students for the Exploration and
Development of Space (SEDS), an organization he founded while earning his undergraduate degree in molecular genetics and graduate degree in aerospace engineering at MIT in 1980. SEDS is the world's largest student pro-space organization.
After MIT he attended Harvard Medical School, where he received his M.D. In 2005 he has was also awarded an honorary Doctorate from the International Space University. Diamandis is the winner of the 2007 Arthur C. Clarke Award for
Innovation, the 2006 (inaugural) Heinlein Award, the 2006 Lindbergh Award, the 2006 Wired RAVE Award, the 2006 Neil Armstrong Award for Aerospace Achievement and Leadership, the Konstantine Tsiolkovsky Award, twice the winner of the
Aviation & Space Technology Laurel, and the 2003 Worl
David Rothkopf is the President and CEO of Garten Rothkopf, an international advisory firm specializing in emerging market investment and risk management services. A major focus of Garten Rothkopf's work is on new trends
in Asia and Latin America, and the growth of alternative energy. Previously, Rothkopf was Founder, Chairman and CEO of Intellibridge, a firm offering open-source intelligence and advisory services on international issues, after serving for
two years as Managing Director of Kissinger Associates. Rothkopf also served as a Senior Trade Official in the Clinton Administration. In this capacity, he played a central role in developing and directing the Administration's
groundbreaking Big Emerging Markets Initiative. A prolific writer, David Rothkopf is the author of more than 150 articles on international themes for publications including the New York Times, Washington Post, Financial Times, Foreign
Affairs, and others. Among his more popular publications are Running the World: The Inside Story of the NSC and the Architects of American Power, and his most recent book, Superclass: The Global Power Elite and the World They Are
Making, which examines the power of global elites and how they are shaping globalization.
Ken Wilcox is president and CEO of SVB Financial Group. Since January 2000, when he took on the role, Wilcox has successfully pursued a strategy of expansion and diversification, while remaining focused on the company's
core niches of technology, life sciences, private equity and premium wineries. Wilcox joined Silicon Valley Bank in 1990 when he co-founded the company's East Coast Technology Division. In this role, Wilcox managed the first regional
office of Silicon Valley Bank and was responsible for all lending activity east of the Mississippi River. Upon promotion to chief banking officer in 1997, Wilcox moved from Massachusetts to California and became president and CEO within
four years. Prior to joining Silicon Valley Bank, Wilcox spent two years as a member of the Technology Lending Group with the Bank of New England and five years at Shawmut Bank in Boston. Prior to his banking career, Wilcox was a professor
of German at The University of North Carolina at Chapel Hill. Wilcox received a bachelor's degree in German studies from Oakland University and a Ph.D. in German Studies from The Ohio State University. He also earned a master's of business
administration from Harvard Business School. Wilcox is a member of the board of directors of the Federal Reserve Bank of San Francisco and the Silicon Valley Leadership Group.
Mir Imran founded InCube Laboratories in 1995 to focus on his passion: creating medical device solutions that change the standard of care in critical healthcare markets. Mir began his career as a med-tech entrepreneur in
the late 1970's. Over the decades, he has become one of the world's most successful inventors, entrepreneurs and investors in healthcare. Mir now holds more than 200 issued patents - and is perhaps most well known for his pioneering
contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator. Mir's current crop of inventions includes advanced treatments for neural aneurysms, epilepsy, ulcerative colitis, obesity and chronic pain, among
others. Most of these will enter clinical trials in the 2008 to 2010 timeframe. As an entrepreneur, Mir has founded over 20 medical device companies, including: Vidamed (acquired by Medtronic), Physiometrix, Cardiac Pathways, Advanced
Cytomextrix (acquired by Oncotech 1997), Percusurge (acquired by Medtronic 2001), Reflow, Inc. (acquired 1999), Safeview (acquired by L3 2006) Intrapace (founded 2001), Spinal Modulation (founded 2005) and Zonare (founded 1999). As an
investor, Mir serves as the Life Science Venture Partner for DFJ ePlanet, where he has led 9 investments in a range of promising ventures around the globe. Mir is also an active angel investor, with a portfolio based around both medical
and pharmaceutical ventures. Mir currently holds board seats with Bodymedia, Cardiovasc, Intrapace, Egeen International, Spinal Modulation, ZARS and Zonare. Mir holds an MS in Bio-Engineering and a BS in Electrical Engineering from
Rutgers, where he spent three years as a Research Specialist.
Brett Crosby is the Group Product Marketing Manager of Google Analytics. He has been shaping the Web Analytics industry for ten years as the co-founder of Urchin Software Corporation and more recently as a senior product
leader at Google. He is currently responsible for product positioning, feature roadmap development and all external product communications. Brett holds a degree from USC in Political Science and International Relations.
Dr. Khanna has been a member of the faculty of the Harvard Business School since 1993, where he studies, and works with, multinational and indigenous companies and investors in emerging markets worldwide. He has served
as course head of the required Strategy course in the Harvard MBA program, and chaired the executive education program on Strategy, Leadership & Governance. Currently, he teaches in Harvard's comprehensive general management executive
education programs. He earned a Bachelors of Science in Engineering degree from Princeton University in 1988, summa cum laude, Phi Beta Kappa, and a Ph.D. in Business Economics from Harvard University in 1993. His current research focuses
on understanding the drivers of entrepreneurship worldwide. As part of the Emerging Giants project, he seeks to understand how to build world-class companies from emerging markets worldwide. A related project, The Dragon and the Elephant,
zeros in on China and India, and identifies best practices for local entrepreneurs and multinationals operating in each of these two countries. His scholarly work is published in a range of journals over the past fifteen years. During this
time, he has continued to serve as a co-editor of several prestigious economics and management journals. A forthcoming book, Billions of Entrepreneurs: How China and India are Reshaping their Futures and Yours, will be published by Harvard
Business School Press (Penguin in South Asia) in 2007. Numerous articles in the Harvard Business Review (e.g. Emerging Giants: Building World Class Companies in Emerging Markets, 2006) and Foreign Policy (e.g. Can India Overtake China?,
2003) distil the implications of this research for practicing managers. Professor Khanna's work has been profiled in news-magazines around the world, including The Wall Street Journal, The Economist, the Far Eastern Economic Review, and
newspapers in China, India, and el
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.